Phenotypic characterization of lymphocytes in HCV/HIV co-infected patients

Viral Immunol. 2009 Feb;22(1):39-48. doi: 10.1089/vim.2008.0074.

Abstract

While hepatitis C virus (HCV)-specific immune responses are attenuated in HCV/HIV co-infected patients compared to those infected with HCV alone, the reasons for this remain unclear. In this study, the proportions of regulatory, naïve, and memory T cells, along with chemokine receptor expression, were measured in co-infected and mono-infected patients to determine if there is an alteration in the phenotypic profile of lymphocytes in these patients. HCV/HIV co-infected patients had increased proportions of CD4(+) naïve cells and decreased proportions of CD4(+) effector cells when compared to HCV mono-infected patients. The proportions of CD4(+) Tregs and CD4(+) CXCR3(+) T cells were also significantly lower in co-infected patients. A decrease in CD4(+) Tregs and subsequent loss of immunosuppressive function may contribute to the accelerated progression to liver disease in co-infected individuals. Dysregulation of immune responses following reduction in the proportions of CD4(+) CXCR3(+) Th-1 cells may contribute to the reduced functional capacity of HCV-specific immune responses in co-infected patients. The findings of this study provide new information on the T-cell immunophenotype in HCV/HIV co-infected patients when compared to those infected with HCV alone, and may provide insight into why cell-mediated immune responses are diminished during HCV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • Female
  • HIV Infections / complications*
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV-1 / immunology*
  • HIV-1 / pathogenicity
  • Hepacivirus / immunology*
  • Hepacivirus / pathogenicity
  • Hepatitis C / complications*
  • Hepatitis C / immunology
  • Hepatitis C / virology
  • Humans
  • Immunophenotyping*
  • Male
  • Middle Aged
  • T-Lymphocytes / immunology*
  • T-Lymphocytes, Regulatory / immunology
  • Young Adult